List of Inventiva Pharma patents | 5 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10383858 PPAR compounds for use in the treatment of fibrotic diseases	Patent 10383858 was granted and assigned to Inventiva Pharma on August, 2019 by the United States Patent and Trademark Office.	Inventiva Pharma	Inventiva Pharma	United States Patent and Trademark Office	10383858	August 20, 2019
‌ US Patent 10052311 PPAR compounds for use in the treatment of fibrotic diseases	Patent 10052311 was granted and assigned to Inventiva Pharma on August, 2018 by the United States Patent and Trademark Office.	Inventiva Pharma	Inventiva Pharma	United States Patent and Trademark Office	10052311	August 21, 2018
‌ US Patent 10414739 Compounds as inhibitors of the YAP/TAZ-TEAD interaction and their use in the treatment of malignant mesothelioma	Patent 10414739 was granted and assigned to Inventiva Pharma on September, 2019 by the United States Patent and Trademark Office.	Inventiva Pharma	Inventiva Pharma	United States Patent and Trademark Office	10414739	September 17, 2019
‌ US Patent 9561246 Use of Odiparcil in the treatment of a mucopolysaccharidosis	Patent 9561246 was granted and assigned to Inventiva Pharma on February, 2017 by the United States Patent and Trademark Office.	Inventiva Pharma	Inventiva Pharma	United States Patent and Trademark Office	9561246	February 7, 2017
‌ US Patent 10092540 Method of treatment of a mucopolysaccharidosis	Patent 10092540 was granted and assigned to Inventiva Pharma on October, 2018 by the United States Patent and Trademark Office.	Inventiva Pharma	Inventiva Pharma	United States Patent and Trademark Office	10092540	October 9, 2018